Leidos wins DARPA contract to develop advanced protective equipment for the US military


The Company’s SPIDERMAN Technology Offers New Defenses Against Chemical and Biological Threats

RESTON, Go., September 29, 2021 /PRNewswire/ — Leidos (NYSE: LDOS), a FORTUNE® 500 science and technology leader, recently won a prime contract from the Defense Advanced Research Projects Agency (DARPA) for its Custom Protective Biosystem (PPB) program. With this award, Leidos will develop technology that reduces the need for bulky protective gear while increasing defense against existing and future chemical and biological (CB) threats. This three-phase contract, lasting five years, at cost plus lump sum, has a total ceiling value of $19.3 million.

Leidos logo. (PRNewsFoto/Leidos)

“Leidos succeeds in meeting the toughest challenges in the world; in this case, protecting frontline personnel from emerging threats through a revolutionary approach to personal protective equipment,” said Leidos’ Chief Technology Officer. jim carlini.

DARPA’s PPB program addresses the nation’s need for lightweight, adaptive personal protective equipment for military and healthcare personnel. The recent pandemic has highlighted this challenge on a global scale.

With this award, Leidos is launching a combination of innovative, robust and flexible platforms known as SPIDERMAN (Smart Protective Integrated Dynamic Ensemble for Reactive, Multifaceted Agent Neutralization). The technology comes in the form of lightweight protective materials and fabric protection countermeasures. It allows protection against CB threats without prior knowledge of the nature of the agent. The goal is to create new and improved ways to deal with different, emerging and uncharacterized threats through advanced technology.

“Leidos has assembled a world-class team and is proud to lead the execution of this groundbreaking program,” said Dr. Jean Dresios, Executive Director of Biology and Principal Investigator of the Leidos PPB team. “SPIDERMAN has the potential to deliver transformative advances that will provide broad and specific protection, as well as rapid and long-lasting protection against chemical and biological threats. We are excited to help design new ways to protect the military and our nation.”

About Leidos
Leidos is a Fortune 500® technology, engineering, and scientific solutions and services leader working to solve the world’s toughest challenges in the defense, intelligence, civilian, and healthcare markets. The company’s 43,000 employees support vital missions for government and commercial customers. Based at Reston, Virginia.Leidos recorded annual revenues of approximately $12.30 billion for the year ended January 1, 2021. For more information, visit www.Leidos.com.

The statements in this announcement, other than historical data and information, are forward-looking statements that involve risks and uncertainties. A number of factors could cause our actual results, performance, achievements or industry results to be materially different from the results, performance or achievements expressed or implied by such forward-looking statements. Some of these factors include, but are not limited to, the risk factors set forth in the company’s annual report on Form 10-K for the period ended January 1, 2021, and other similar filings that Leidos makes from time to time with the SEC. Because of these uncertainties and risks, readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof.


Melissa Duenas
(571) 526-6850
[email protected]

Thomas Doheny
(571) 474-4735
[email protected]

Alyssa Pettus
(571) 992-5499
[email protected]



View original content to download multimedia: https://www.prnewswire.com/news-releases/leidos-awarded-darpa-contract-to-develop-advanced-protective-equipment-for-us-military-301387503.html

SOURCELeidos Holdings, Inc.


Comments are closed.